Mycrodose Therapeutics to Discuss Advanced Drug Delivery Devices at Psychedelic Medicine Event
San Diego, California--(Newsfile Corp. - July 27, 2021) - Mycrodose Therapeutics, a US-Based pharmaceutical company focused on developing advanced drug delivery systems for use with psychedelic compounds, announced today that its Executive team will be participating in the upcoming Psychedelic Capital Event on July 29, 2021. The virtual conference hosted by Microdose Psychedelic Insights will enable Mycrodose Therapeutics the opportunity to present as a panel on the company’s core drug...
2021-07-27 10:18 AM EDT
Microdose Is Pleased to Announce the DMT Conference: A Molecular Masterclass
Get a free ticket to the event here: https://microdose.buzz/nwdmtToronto, Ontario--(Newsfile Corp. - July 27, 2021) - Microdose in partnership with Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1), a biotechnology company focused on developing psychedelic medicines to treat addiction, Algernon Pharmaceuticals Inc. (CSE: AGN) a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and COVID-19, and...
2021-07-27 7:00 AM EDT
Drug Delivery and Supply Chain in the Psychedelic Medicine Industry
Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - Microdose Psychedelic Insights is proud to announce the upcoming Psychedelic Capital: July 2021 conference to be taking place on July 29, 2021. The July edition will tackle Drug Delivery and Supply Chain in the Psychedelic Medicine Industry. Click here to get a free ticket: https://microdose.buzz/pressreleaseThe virtual event will seek to provide attendees with some of the top companies, latest IPOs, newest opportunities, and deepest...
2021-07-22 7:00 AM EDT
Microdose Psychedelic Insights Closes Oversubscribed Financing Round
Charlie Finnie joins Microdose Psychedelic Insights' Board of Directors Toronto, Ontario--(Newsfile Corp. - July 7, 2021) - Microdose Psychedelic Insights, a privately held media company, announced today that it has closed a seven figure oversubscribed round, Charlie Finnie, Chief Executive Officer of Origin Therapeutics joins as a board member. Investors in this...
2021-07-07 7:00 AM EDT
June Psychedelic Capital Marks Annual Birthday of Conference Series
Toronto, Ontario--(Newsfile Corp. - June 21, 2021) - Microdose Psychedelic Insights is proud to announce the upcoming Psychedelic Capital: June 2021 conference to be taking place on June 30, 2021. Click here to get a free ticket: https://microdose.buzz/pressreleaseThe virtual event will seek to provide attendees with some of the top companies, latest IPOs, newest opportunities, and deepest industry insights within the sector.Part of an investor conference series diving deep into psychedelic...
2021-06-21 2:00 PM EDT
Microdose Psychedelic Insights Announces Wonderland Miami
Toronto, Ontario--(Newsfile Corp. - June 9, 2021) - Microdose Psychedelic Insights is thrilled to announce the inaugural psychedelic medicine real-world event, Wonderland: Miami.Wonderland: Miami will bring together an impressive group of global psychedelic medicine leaders, including scientists and researchers, investors and entrepreneurs, therapists and patients, government officials and media, all championing the growth of the psychedelic medicine industry. After a successful year of over...
2021-06-09 10:00 AM EDT
Circadian Wellness Inc. Chief Operating Officer Will Present at a Psychedelic Capital Event Hosted by Microdose(TM)
Toronto, Ontario--(Newsfile Corp. - May 31, 2021) - Today, functional mushroom company Circadian Wellness will have a member of their leadership team presenting at the virtual Psychedelic Capital event hosted by MicroDose™. Chief Operating Officer, Alex Wolfe will be providing his perspective about the functional and psychedelic mushroom landscape and the future of the industry."We are delighted to share our perspective, learn and support fellow industry leaders in a unique event. We all...
2021-05-31 8:34 AM EDT
May Psychedelic Capital Investigates Financial Media and Equality in the Boardroom
Toronto, Ontario--(Newsfile Corp. - May 27, 2021) - Microdose Psychedelic Insights ("Microdose"), your guide to the business of psychedelics, in partnership with The Conscious Fund, the most active VC fund in the psychedelic space, is pleased to present the next edition of Psychedelic Capital. The next edition of the psychedelic investment series will be on Monday, May 31, 2021, at 1:30 PM EST. The PsyCap May edition will feature engaging presentations from Psyched Wellness (CSE: PSYC) (OTCQB:
2021-05-27 9:30 AM EDT
Microdose is Pleased to Announce The MDMA Conference: A Molecular Masterclass -- and We're Calling for Speakers
Toronto, Ontario--(Newsfile Corp. - May 17, 2021) - Microdose Psychedelic Insights ("Microdose"), your guide to the business of psychedelics, in partnership with Pharmala Biotech Inc. a Canadian Biotechnology company dedicated to the domestic manufacture of clinical-grade MDMA and ACS Pharmacology & Translational Science, are pleased to announce the MDMA Conference and an open call for speakers. The one-day virtual conference is to take place on June 15th, starting at 9am EST. Are you an...
2021-05-17 11:16 AM EDT
Psyched Wellness to Present at the Psychedelic Investment Series on Monday, May 31, 2021
Toronto, Ontario--(Newsfile Corp. - May 11, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company will be participating in the upcoming Psychedelic Capital virtual event. Psyched will be presenting at the next edition of the psychedelic investment...
2021-05-11 5:01 PM EDT
April Psychedelic Capital Investigates Clinical Trials & Real World Evidence & Going Mainstream: Mass Adoption
Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - Microdose Psychedelic Insights ("Microdose"), the leader in B2B psychedelic intelligence, in partnership with The Conscious Fund, the most active VC fund in the psychedelic space, is pleased to present the next edition of Psychedelic Capital. The next edition of the psychedelic investment series will be on Thursday, April 29, 2021, at 1:30 PM EST. The PsyCap April edition will feature engaging presentations from NanoPsy, BETTERLIFE PHARMA...
2021-04-28 9:00 AM EDT
Heroic Dose Event Explores Promise of Psychedelic Medicine for Veterans, Military & Servicemen and Women
Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - Microdose Psychedelic Insights, along with Entheon Biomedical Corp., Bexson Biomedical, HavnLife and The Conscious Fund, present the Heroic Dose.The Heroic Dose will commence on 22nd April at 8:45 am EST. This one-day virtual conference explores the use of psychedelic therapies for military veterans and first responders in an effort to combat the alarming rates
2021-04-08 8:00 AM EDT
March Psychedelic Capital Investigates Ethical IP and Financial Instruments
Toronto, Ontario--(Newsfile Corp. - March 30, 2021) - Microdose Psychedelic Insights ("Microdose"), the leader in B2B psychedelic intelligence, in partnership with The Conscious Fund, the most active VC fund in the psychedelic space, is pleased to present the next edition of Psychedelic Capital. #PsyCap is taking place on March 31 at 1:30pm EST and will feature engaging presentations from Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink: ENTBF) (FSE: 1XU1), Mind Cure
2021-03-30 8:30 AM EDT
Psychedelic Masterclass Spotlights Ketamine as a Novel Mental Health Medicine
Toronto, Ontario--(Newsfile Corp. - July 30, 2020) - Microdose Psychedelic Insights, along with Bexson Biomedical, The Conscious Fund, and Ketamine Media presents The Ketamine Conference: A Molecular Masterclass, a two-day virtual conference. On August 21st - 22nd, over 30 experts will guide attendees through the potential mental health benefits of ketamine-assisted therapy, along with its intersections with clinical care, research, and business opportunities.The organizers have invited some...
2020-07-30 7:15 AM EDT